NO905012L - Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten. - Google Patents
Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.Info
- Publication number
- NO905012L NO905012L NO90905012A NO905012A NO905012L NO 905012 L NO905012 L NO 905012L NO 90905012 A NO90905012 A NO 90905012A NO 905012 A NO905012 A NO 905012A NO 905012 L NO905012 L NO 905012L
- Authority
- NO
- Norway
- Prior art keywords
- oxacefemer
- cefemer
- carbacefemer
- sulphonyloxy
- substituted
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43976789A | 1989-11-21 | 1989-11-21 | |
US07/603,872 US5245027A (en) | 1989-11-21 | 1990-10-31 | 3-fluorosulfonyloxyceph-3-em compounds |
Publications (4)
Publication Number | Publication Date |
---|---|
NO905012D0 NO905012D0 (no) | 1990-11-20 |
NO905012L true NO905012L (no) | 1991-05-22 |
NO177348B NO177348B (no) | 1995-05-22 |
NO177348C NO177348C (no) | 1995-08-30 |
Family
ID=27032165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO905012A NO177348C (no) | 1989-11-21 | 1990-11-20 | Fremgangsmåte til fremstilling av et cefalosporin-antibiotikum, samt 3-(fluorsulfonyl)oksy-substituerte cefemer og karbacefemer |
Country Status (14)
Country | Link |
---|---|
US (2) | US5245027A (no) |
EP (1) | EP0431794A3 (no) |
JP (1) | JP2964423B2 (no) |
KR (1) | KR0148488B1 (no) |
AU (1) | AU637650B2 (no) |
CA (1) | CA2030361C (no) |
FI (1) | FI97545C (no) |
HU (2) | HU213400B (no) |
IE (1) | IE904191A1 (no) |
IL (1) | IL96417A (no) |
NO (1) | NO177348C (no) |
NZ (1) | NZ236183A (no) |
OA (1) | OA09329A (no) |
RU (2) | RU2044738C1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3224279B2 (ja) * | 1992-07-27 | 2001-10-29 | 大塚化学株式会社 | セフエム化合物の製造法 |
JP4510957B2 (ja) | 1999-09-01 | 2010-07-28 | 大塚化学株式会社 | セフェム化合物の製造方法 |
KR100459387B1 (ko) * | 2001-10-29 | 2004-12-03 | 한동기 | 인스탄트 돈가스 소스용 조성물 및 레토르트파우치 제품제조방법 |
JP5443118B2 (ja) * | 2009-03-31 | 2014-03-19 | 三菱マテリアル株式会社 | ビス(フルオロスルホニル)イミド塩の製造方法、ビス(フルオロスルホニル)イミド塩及びフルオロ硫酸塩の製造方法、並びにビス(フルオロスルホニル)イミド・オニウム塩の製造方法 |
CN102718714B (zh) * | 2012-06-26 | 2014-09-17 | 天津师范大学 | 蒽桥联的四齿咪唑盐及其制备方法与应用 |
CN111689929B (zh) * | 2014-06-06 | 2024-05-31 | 斯克里普斯研究所 | 氟化硫(vi)化合物及其制备方法 |
CN106687441A (zh) * | 2014-10-08 | 2017-05-17 | 陶氏环球技术有限责任公司 | 用于将第一化合物偶合到第二化合物的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR207327A1 (es) * | 1974-02-06 | 1976-09-30 | Lilly Co Eli | Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres |
US4520022A (en) * | 1983-01-28 | 1985-05-28 | Bristol-Myers Company | Substituted vinyl cephalosporins |
AU575854B2 (en) * | 1983-10-04 | 1988-08-11 | Shionogi & Co., Ltd. | 7beta-(carboxyalkenamido) cephalosporins |
AU580855B2 (en) * | 1985-03-29 | 1989-02-02 | Shionogi & Co., Ltd. | Alkeneamidocephalosporin esters |
US4820816A (en) * | 1985-08-02 | 1989-04-11 | President And Fellows Of Harvard College | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics |
US4870168A (en) * | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
US4820832A (en) * | 1988-03-23 | 1989-04-11 | Eli Lilly And Company | Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins |
US4855418A (en) * | 1988-03-23 | 1989-08-08 | Eli Lilly And Company | Process for production of ceophalosporins |
-
1990
- 1990-10-31 US US07/603,872 patent/US5245027A/en not_active Expired - Lifetime
- 1990-11-19 FI FI905699A patent/FI97545C/fi not_active IP Right Cessation
- 1990-11-20 IE IE419190A patent/IE904191A1/en unknown
- 1990-11-20 OA OA59898A patent/OA09329A/xx unknown
- 1990-11-20 CA CA002030361A patent/CA2030361C/en not_active Expired - Fee Related
- 1990-11-20 KR KR1019900018826A patent/KR0148488B1/ko not_active IP Right Cessation
- 1990-11-20 NO NO905012A patent/NO177348C/no unknown
- 1990-11-20 AU AU66770/90A patent/AU637650B2/en not_active Ceased
- 1990-11-20 EP EP19900312623 patent/EP0431794A3/en not_active Ceased
- 1990-11-20 IL IL9641790A patent/IL96417A/en unknown
- 1990-11-21 HU HU9303608A patent/HU213400B/hu not_active IP Right Cessation
- 1990-11-21 HU HU907221A patent/HU209309B/hu not_active IP Right Cessation
- 1990-11-21 JP JP2314479A patent/JP2964423B2/ja not_active Expired - Fee Related
- 1990-11-21 RU SU904831927A patent/RU2044738C1/ru active
- 1990-11-21 NZ NZ236183A patent/NZ236183A/en unknown
-
1992
- 1992-09-09 RU SU925052625A patent/RU2070200C1/ru not_active IP Right Cessation
-
1993
- 1993-06-15 US US08/077,825 patent/US5420269A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2030361C (en) | 2001-01-30 |
NO177348C (no) | 1995-08-30 |
CA2030361A1 (en) | 1991-05-22 |
IE904191A1 (en) | 1991-05-22 |
FI97545B (fi) | 1996-09-30 |
KR910009713A (ko) | 1991-06-28 |
JPH03220195A (ja) | 1991-09-27 |
NO177348B (no) | 1995-05-22 |
JP2964423B2 (ja) | 1999-10-18 |
HU209309B (en) | 1994-04-28 |
HU9303608D0 (en) | 1994-04-28 |
US5245027A (en) | 1993-09-14 |
US5420269A (en) | 1995-05-30 |
HU907221D0 (en) | 1991-05-28 |
FI905699A0 (fi) | 1990-11-19 |
NO905012D0 (no) | 1990-11-20 |
AU6677090A (en) | 1991-05-30 |
RU2070200C1 (ru) | 1996-12-10 |
HUT66487A (en) | 1994-11-28 |
EP0431794A3 (en) | 1992-03-25 |
KR0148488B1 (ko) | 1998-11-02 |
NZ236183A (en) | 1992-03-26 |
FI905699A (fi) | 1991-05-22 |
AU637650B2 (en) | 1993-06-03 |
FI97545C (fi) | 1997-01-10 |
IL96417A (en) | 1995-03-15 |
HU213400B (en) | 1997-06-30 |
IL96417A0 (en) | 1991-08-16 |
OA09329A (fr) | 1992-09-15 |
RU2044738C1 (ru) | 1995-09-27 |
EP0431794A2 (en) | 1991-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO900547L (no) | Fremgangsmaate til dehydrogenering av alkaner. | |
NO870890L (no) | Fremgangsmte for fremstilling av aromatiske 2-aminoalkyl-1,2-benzoisothiazol-3-(2h)-on-1,1-dioxyd-derivater. | |
NO914751D0 (no) | N,o-sulfaterte heparosaner, fremgangsmaate ved fremstilling av dem og farmasoeytiske blandinger inneholdende dem | |
NO167747C (no) | Fremgangsmaate for fremstilling av tetra-n-acetyl-kitotetraose, penta-n-acetyl-kitopentaose og heksa-n-acetyl-kitoheksaose ved delvis hydrolyse av kitin. | |
NO871602D0 (no) | 1-hydroksy-2-pyridoner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem samt ved fremstillingen av 1-hydroksy-2-pyridoner dannede mellomprodukter. | |
NO864241L (no) | Fremgangsmaate ved bleking av cellulosemasse eller fraksjon derav, anlegg til bruk ved gjennomfoeringen av fremgangsmaaten og skruepresse, saerlig til bruk ved fremgangsmaaten henholdsvis i anlegget. | |
NO904471D0 (no) | Fremgangsmaate for fremstilling av partikkelformig titandioxyd. | |
NO166032C (no) | Fremgangsmaate ved fremstilling av triklormonosilan. | |
NO895067D0 (no) | Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose. | |
ES2021411B3 (es) | Proceso para la preparacion de (2,2) paraciclofano. | |
NO905444L (no) | Fremgangsmaate til fremstilling av oksazolderivater. | |
NO905012L (no) | Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten. | |
NO960307D0 (no) | Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner | |
NO903347L (no) | 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler. | |
EP0421216A3 (en) | Process for the preparation of 2,4, resp. 2,6 dihalo-aniline | |
NO881487L (no) | Fremgangsmaate til fremstilling av alfa-(1-metyletyl)-3,4-dimetoksybenzen-xen-acetonitril, samt mellomprodukt som dannes ved fremgangsmaaten. | |
NO903741D0 (no) | Fremgangsmaate ved fremstilling av emballasje. | |
EP0663207A3 (en) | Bamboo salt manufacturing process. | |
NO905244D0 (no) | Fremgangsmaate for fremstilling av des(64,65)-proinsulin. | |
NO882028L (no) | Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner. | |
NO874617D0 (no) | Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner. | |
NO913069L (no) | Fremgangsmaate ved bekjempelse av granbarkbiller. | |
NO901892L (no) | Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter. | |
NO870889L (no) | Fremgangsmte for fremstilling av aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater. | |
NO901454D0 (no) | Fremgangsmaate til fremstilling av n-metyl-3,4-dimetoksyfenyletylamin. |